Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin in children with acute otitis media
NCT00638534Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2004
- Primary completion
- Oct 2004
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of telithromycin in acute otitis media (AOM), sponsored by Sanofi. Started Feb 2004; status: completed.
02
Drugs
telithromycin
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00638534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638534.